Fatanah Ventures

Fatanah Ventures (Fatanah) is a portfolio investment company, the brainchild of former CEO CommerceNet Singapore, Dr. Wong Jeh Shyan, CEO Precession Capital Berhad  Nazril “Nash” Idrus, and former CEO of Bursa Malaysia Dato’ Yusli Yusof (Almarhum).

Nazril “Nash” Idrus

CEO Precession Capital Berhad 

Dr. Wong Jeh Shyan

CEO CommerceNet Singapore

Dato’ Yusli Yusof

CEO of Bursa Malaysia

Co - Founders

Jalil Rasheed

Former CEO Berjaya Group / Former CEO
PNB & Permodalan Nasional Berhad

Tan Sri Jamaludin Ibrahim

Former Chairman AXIATA Berhard/
Former CEO Maxis

Johan Ishak

former CEO Media Prima TV Networks

Surina Shukri

former CEO MDEC, was also due to join
Fatanah & Former JP Morgan Chase NY

Meaning

Fatanah means “wisdom” (act of “fardu kifayah”), includes attitude that encompass intelligence, knowledge, disciplined, proactive, and ability to make the best decisions.

Fatanah Ventures have worked with very credible people: Former top CEOs of industries, high echelon thought leaders, as well as business tycoons - who continue to impart their invaluable experiences and wisdom -  to a growing number of business owners, entrepreneurs and C-suites in the SME landscape.

Mandate

Fatanah Ventures mandate is to support the growth of SMEs in the areas of amongst others :

People

Some great people who have shared their wisdom, experiences, and mentoring are:

Tan Sri Dato Sri Dr Abdul Aziz Rahman

Chairman, Universiti Malaysia Pahang UMP

Tan Sri Abdul Wahid Omar (AWO)

Chairman, Bursa Malaysia; Former CEO, Maybank | Telekom M’sia

Dr. Wong Jeh Shyan

CEO CommerceNet Singapore

Portfolio

The companies that Fatanah has invested are:

ALPS Global Berhad​

Will be listed at Nasdaq with target IPO
valuation USD1.6 billion, 2025

Superbig Capital Berhad

Target IPO valuation RM300 million, 2028
Current valuation RM100 million

Haos Berhad

Target IPO valuation RM1 billion, 2027
Current Valuation RM20 million

BioV Global Berhad

Current valuation at RM42 million

IPO target in 2029

Evergrown Holdings Berhad

Current valuation at RM310 million

IPO target in 2028

Ginseng World Biotech Berhad

Current Valuation RM216 mil
Target IPO Year 2027